FDA OKs New Kids' Dose of Cancer Drug
WASHINGTON -- The FDA has approved a pediatric dosage of the cancer drug everolimus (Afinitor Disperz) for the treatment of a rare brain tumor. (Source: MedPage Today Product Alert)
Source: MedPage Today Product Alert - August 30, 2012 Category: Drugs & Pharmacology Source Type: alerts